YangXinShi
- Generic Name
- YangXinShi
Effects of Yangxinshi Pills on the Exercise Tolerance Compared With Trimetazidine in Patients After PCI
Phase 4
- Conditions
- Percutaneous Coronary Intervention
- Interventions
- First Posted Date
- 2019-01-18
- Last Posted Date
- 2020-10-19
- Lead Sponsor
- Shenyang Northern Hospital
- Target Recruit Count
- 668
- Registration Number
- NCT03809273
- Locations
- 🇨🇳
Beijing Anzhen Hospital, Capital Medical University, Beijing, Beijing, China
🇨🇳The First Affiliated Hospital of University of Science and Technology of China, Hefei, Anhui, China
🇨🇳Hebei General Hospital, Shijiazhuang, Hebei, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath